Wyndham Hotels & Resorts (WH) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
22 Oct, 2026Executive summary
Q3 net revenues rose 7% to $410M; comparable adjusted EBITDA increased 5% to $207M and adjusted diluted EPS rose 9% to $1.43.
Global RevPAR increased 2% in constant currency, while U.S. RevPAR rose 6%; system rooms grew 4% excluding Revo.
The record development pipeline reached ~264,000 rooms; full-year RevPAR and adjusted EBITDA outlooks were raised.
Financial highlights
Q3 net income fell 6% to $99M; reported adjusted EBITDA declined 3% to $207M, while comparable adjusted EBITDA grew 5%.
Q3 diluted EPS was $1.33 versus $1.36; adjusted diluted EPS was $1.43, up 9% on a comparable basis.
Q3 free cash flow was $100M and operating cash flow was $93M; YTD free cash flow was $269M.
Q3 revenue gains included $9M each from royalties/franchise fees and marketing, reservation and loyalty fees, plus $6M in management and other fees and $4M in ancillary revenue.
9M revenue rose 2% to $1.112B and net income increased 4% to $262M; 9M adjusted EBITDA rose 4% to $575M.
Outlook and guidance
FY 2026 global RevPAR outlook rose to 0.5%-1.0%; net revenues are forecast at $1.480B-$1.495B and adjusted EBITDA at $740M-$745M.
Adjusted net income is projected at $363M-$369M and adjusted diluted EPS at $4.84-$4.92; free cash flow conversion is expected at 55%-60% of adjusted EBITDA.
FY net room growth outlook is ~4%, excluding Revo-related rooms; assumptions include Q4 domestic RevPAR in line with Q3.
Core adjusted EBITDA growth is expected at ~6%-7%, excluding return of variable costs and Revo Hospitality Group fee deferral.
Each 1% RevPAR change is estimated to affect net revenues by $10M and adjusted EBITDA by $4M; a sharper demand pullback could put results below estimates.
Latest events from Wyndham Hotels & Resorts
- Record room growth and pipeline support 2024 Adjusted EBITDA guidance of $690–$700M.WH
Q4 2023 - Q2 2026: net income up 17%, system and pipeline up 4%, guidance raised, strong capital returns.WH
Q2 2026 - 4% net room growth, $327M revenue, and record pipeline drive raised outlook and strong cash returns.WH
Q1 2026 - Strong 2025 results, robust governance, and ESG focus; board opposes written consent proposal.WH
Proxy filing - Annual meeting to vote on directors, pay, auditor, and written consent proposal.WH
Proxy filing - Record room growth, resilient earnings, and strong tech investments drive a positive 2026 outlook.WH
Q4 2025 - Q3 delivered 4% room growth, $208M EBITDA, record pipeline, and raised 2024 guidance.WH
Q3 2024 - Q2 saw 4% room growth, 22% higher adjusted EPS, and record pipeline expansion.WH
Q2 2024 - Record room growth and resilient earnings, but 2025 outlook trimmed on RevPAR softness.WH
Q1 2025